Baptisia Tinctoria, Phytolacca Decandra, Apis Mellifica, Belladonna, Lachesis Mutus, Mercurius Solubilis, Hepar Sulphuris Calcareum
Generic Name: baptisia tinctoria, phytolacca decandra, apis mellifica, belladonna, lachesis mutus, mercurius solubilis, hepar sulphuris calcareum
Brand Names:
Throat Formula
INDICATIONS: For temporary relief of swollen tonsils, throat pain and burning of the throat.
Overview
INDICATIONS: For temporary relief of swollen tonsils, throat pain and burning of the throat.
Uses
INDICATIONS: For temporary relief of swollen tonsils, throat pain and burning of the throat.
Dosage
DIRECTIONS: Spray orally 4-6 times daily. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Frequently Asked Questions
What is Baptisia Tinctoria, Phytolacca Decandra, Apis Mellifica, Belladonna, Lachesis Mutus, Mercurius Solubilis, Hepar Sulphuris Calcareum used for?▼
INDICATIONS: For temporary relief of swollen tonsils, throat pain and burning of the throat.
What are the important warnings for Baptisia Tinctoria, Phytolacca Decandra, Apis Mellifica, Belladonna, Lachesis Mutus, Mercurius Solubilis, Hepar Sulphuris Calcareum?▼
WARNINGS: If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Related Medications
Romosozumab
romosozumab
Dosage form: INJECTION, SOLUTION. Active ingredients: ROMOSOZUMAB (105 mg/1.17mL). Category: DRUG FOR FURTHER PROCESSING.
Methdilazine
methdilazine
Manufactured by WESTWOOD SQUIBB. Dosage form: TABLET. Route: ORAL. Active ingredients: METHDILAZINE HYDROCHLORIDE (8MG). Application: NDA011950.
Emtricitabine, Rilpivirine And Tenofovir Disoproxil Fumarate
emtricitabine, rilpivirine and tenofovir disoproxil fumarate
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
11 DESCRIPTION Emtricitabine, rilpivirine and tenofovir disoproxil fumarate tablets are a fixed-dose combination tablet containing FTC, rilpivirine hydrochloride, and TDF. Emtricitabine, USP (FTC) is a synthetic nucleoside analog of cytidine. Rilpivirine (RPV) is a non-nucleoside reverse transcriptase inhibitor. Tenofovir disoproxil fumarate (TDF) is converted in vivo to tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.